Amorepacific Corporation (090435.KS)
ValueMarkers Composite Index
DCF data not available
Amorepacific Corporation (090435.KS) — VMCI valuation read
Headline read on 090435.KS: VMCI of 64/100 versus a broad-market sample median of 50. The 14-point above-median position is what makes Amorepacific Corporation a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on 090435.KS: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on 090435.KS: value (090435.KS trades at 17.0x earnings, 6% below the sector median of 18.0x), quality (ROIC of 15.0% sits 5.0pp above the sector median (10.0%)), and risk (net debt to EBITDA of 1.9x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the sector 12.0x baseline.
090435.KS rose 3.4% over the trailing 7 days, with a -22.7% read on a 30-day basis.
Amorepacific Corporation manufactures and sells beauty, household, and healthcare products worldwide. The company offers skincare products, cleansers, toners and fluids, moisturizers, eye care products, serums, masks, and special care and travel products. It provides anti-ageing, dryness, tone and texture, sun protection, and makeup products. The company was founded in 1945 and is based in Seoul, South Korea.
Related Stocks
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.